Diagnosis and Monitoring of Chronic Myeloid Leukemia: Chiang Mai University Experience.

@article{Tantiworawit2016DiagnosisAM,
  title={Diagnosis and Monitoring of Chronic Myeloid Leukemia: Chiang Mai University Experience.},
  author={A. Tantiworawit and Supanat Kongjarern and E. Rattarittamrong and S. Lekawanvijit and Kanokkan Bumroongkit and N. Boonma and Thanawat Rattanathammethee and Sasinee Hantrakool and Chatree Chai-Adisaksopha and L. Norasetthada},
  journal={Asian Pacific journal of cancer prevention : APJCP},
  year={2016},
  volume={17 4},
  pages={
          2159-64
        }
}
  • A. Tantiworawit, Supanat Kongjarern, +7 authors L. Norasetthada
  • Published 2016
  • Medicine
  • Asian Pacific journal of cancer prevention : APJCP
    • BACKGROUND A diagnosis of chronic myeloid leukemia (CML) is made on discovery of the presence of a Philadelphia (Ph) chromosome. The success of the treatment of this form of leukemia with tyrosine kinase inhibitor (TKI) is monitored by reduction of the Ph chromosome. OBJECTIVE To compare the role of conventional cytogenetic (CC) methods with a real time quantitative polymerase chain reaction (RQ-PCR) and fluorescence in situ hybridization (FISH) for diagnosis and treatment monitoring of CML… CONTINUE READING
    View PDF
    4 Citations
    Background Citations
    1
    Methods Citations
    1
    4 Citations
    Citation Type

    Citation Type

    The role of cytogenetics and molecular biology in the diagnosis, treatment and monitoring of patients with chronic myeloid leukemia
    • 1
    • PDF
    Practical Laboratory Tools for Monitoring of BCR-ABL1 Transcripts and Tyrosine Kinase (TK) Domain Mutations in Chronic Myeloid Leukemia Patients Undergoing TK Inhibitor Therapy: A Single-Center Experience in Thailand
    • PDF
    Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia
    Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression
    • 14

    References

    SHOWING 1-10 OF 30 REFERENCES
    Treatment and Survival in Patients with Chronic Myeloid Leukemia in a Chronic Phase in West Iran.
    • 11
    • PDF
    Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV.
    • 209
    • PDF
    Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score.
    • 343
    • PDF
    Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
    • 1,988
    Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP.
    • 77
    • PDF
    Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina.
    • 67
    • PDF
    Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
    • 3,234
    • PDF
    Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.
    • 1,174
    • PDF
    A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.
    • 696
    • PDF
    Prognostic discrimination in "good-risk" chronic granulocytic leukemia
    • 724
    • PDF